BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9423838)

  • 1. Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.
    Donnenberg MS; Tacket CO; Losonsky G; Frankel G; Nataro JP; Dougan G; Levine MM
    Infect Immun; 1998 Jan; 66(1):52-8. PubMed ID: 9423838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
    Donnenberg MS; Tacket CO; James SP; Losonsky G; Nataro JP; Wasserman SS; Kaper JB; Levine MM
    J Clin Invest; 1993 Sep; 92(3):1412-7. PubMed ID: 8376594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.
    Levine MM; Nataro JP; Karch H; Baldini MM; Kaper JB; Black RE; Clements ML; O'Brien AD
    J Infect Dis; 1985 Sep; 152(3):550-9. PubMed ID: 2863318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
    Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
    Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants.
    Martinez MB; Taddei CR; Ruiz-Tagle A; Trabulsi LR; Girón JA
    J Infect Dis; 1999 Jan; 179(1):269-74. PubMed ID: 9841853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of EspB in experimental human enteropathogenic Escherichia coli infection.
    Tacket CO; Sztein MB; Losonsky G; Abe A; Finlay BB; McNamara BP; Fantry GT; James SP; Nataro JP; Levine MM; Donnenberg MS
    Infect Immun; 2000 Jun; 68(6):3689-95. PubMed ID: 10816529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain.
    Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC
    Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the eaeA gene from rabbit enteropathogenic Escherichia coli strain RDEC-1 and comparison to other eaeA genes from bacteria that cause attaching-effacing lesions.
    Agin TS; Cantey JR; Boedeker EC; Wolf MK
    FEMS Microbiol Lett; 1996 Nov; 144(2-3):249-58. PubMed ID: 8900070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vaccination of weaned rabbits against enteropathogenic Escherichia coli-like E. coli O103 infection: use of heterologous strains harboring lipopolysaccharide or adhesin of pathogenic strains.
    Milon A; Esslinger J; Camguilhem R
    Infect Immun; 1992 Jul; 60(7):2702-9. PubMed ID: 1351880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human colostrum and serum contain antibodies reactive to the intimin-binding region of the enteropathogenic Escherichia coli translocated intimin receptor.
    Sanches MI; Keller R; Hartland EL; Figueiredo DM; Batchelor M; Martinez MB; Dougan G; Careiro-Sampaio MM; Frankel G; Trabulsi LR
    J Pediatr Gastroenterol Nutr; 2000 Jan; 30(1):73-7. PubMed ID: 10630443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge.
    Boullier S; Nougayrède JP; Marchès O; Tasca C; Boury M; Oswald E; De Rycke J; Milon A
    Microbes Infect; 2003 Aug; 5(10):857-67. PubMed ID: 12919854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection.
    Ahmed S; Byrd W; Kumar S; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):146-55. PubMed ID: 23084628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.
    Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC
    Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies.
    Parissi-Crivelli A; Parissi-Crivelli JM; Girón JA
    J Clin Microbiol; 2000 Jul; 38(7):2696-700. PubMed ID: 10878066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.
    Gansheroff LJ; Wachtel MR; O'Brien AD
    Infect Immun; 1999 Dec; 67(12):6409-17. PubMed ID: 10569757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the Escherichia coli attaching and effacing gene (eaeA) in enteropathogenic strains by polymerase chain reaction.
    Germani Y; Bégaud E; Le Bouguénec C
    Res Microbiol; 1997 Feb; 148(2):177-81. PubMed ID: 9765798
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and characteristics of enteropathogenic Escherichia coli with the eae gene in diarrhoeic rabbits.
    Blanco JE; Blanco M; Blanco J; Mora A; Balaguer L; Cuervo L; Balsalobre C; Muñoa F
    Microbiol Immunol; 1997; 41(2):77-82. PubMed ID: 9087949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing of intimin (eae) genes from enteropathogenic Escherichia coli (EPEC) isolated from children with diarrhoea in Montevideo, Uruguay: identification of two novel intimin variants (muB and xiR/beta2B).
    Blanco M; Blanco JE; Dahbi G; Mora A; Alonso MP; Varela G; Gadea MP; Schelotto F; González EA; Blanco J
    J Med Microbiol; 2006 Sep; 55(Pt 9):1165-1174. PubMed ID: 16914645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens.
    Adu-Bobie J; Frankel G; Bain C; Goncalves AG; Trabulsi LR; Douce G; Knutton S; Dougan G
    J Clin Microbiol; 1998 Mar; 36(3):662-8. PubMed ID: 9508292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to outer membrane proteins of Escherichia coli in healthy persons and patients with bacteremia.
    Henriksen AZ; Maeland JA
    J Clin Microbiol; 1987 Nov; 25(11):2181-8. PubMed ID: 3320085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.